HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study. - Chang, Xu; Li, Xinge; Sun, Peng; Li, Zhenfeng; Sun, Pengfei; Ning, Shangkun (BMC Cancer, 2024)